Stoppa-Lyonnet D - Search Results

1

Safety of the Breast Cancer Adjuvant Radiotherapy in Ataxia-Telangiectasia Mutated Variant Carriers.

Bensenane R, Beddok A, Lesueur F, Fourquet A, Warcoin M, Le Mentec M, Cavaciuti E, Le Gal D, Eon-Marchais S, Andrieu N, Stoppa-Lyonnet D, Kirova Y. Bensenane R, et al. Among authors: stoppa lyonnet d. Cancers (Basel). 2024 Apr 5;16(7):1417. doi: 10.3390/cancers16071417. Cancers (Basel). 2024. PMID: 38611095 Free PMC article.

2

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families.

Janin N, Andrieu N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D. Janin N, et al. Br J Cancer. 1999 Jun;80(7):1042-5. doi: 10.1038/sj.bjc.6690460. Br J Cancer. 1999. PMID: 10362113 Free PMC article.

3

Low expression of bcl-2 in Brca1-associated breast cancers.

Freneaux P, Stoppa-Lyonnet D, Mouret E, Kambouchner M, Nicolas A, Zafrani B, Vincent-Salomon A, Fourquet A, Magdelenat H, Sastre-Garau X. Freneaux P, et al. Br J Cancer. 2000 Nov;83(10):1318-22. doi: 10.1054/bjoc.2000.1438. Br J Cancer. 2000. PMID: 11044356 Free PMC article.

4

Familial invasive breast cancers: worse outcome related to BRCA1 mutations.

Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, Clough KB, Magdelénat H, Pouillart P, Vincent-Salomon A, Fourquet A, Asselain B. Stoppa-Lyonnet D, et al. J Clin Oncol. 2000 Dec 15;18(24):4053-9. doi: 10.1200/JCO.2000.18.24.4053. J Clin Oncol. 2000. PMID: 11118466

5

Cancer risk in heterozygotes for ataxia-telangiectasia.

Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Croquette MF, Griscelli C, Debré M, Bressac-de-Paillerets B, Aurias A, Stoppa-Lyonnet D, Andrieu N. Geoffroy-Perez B, et al. Int J Cancer. 2001 Jul 15;93(2):288-93. doi: 10.1002/ijc.1329. Int J Cancer. 2001. PMID: 11410879

6

Variation in breast cancer risk of heterozygotes for ataxia-telangiectasia according to environmental factors.

Geoffroy-Perez B, Janin N, Ossian K, Laugé A, Stoppa-Lyonnet D, Andrieu N. Geoffroy-Perez B, et al. Int J Cancer. 2002 Jun 1;99(4):619-23. doi: 10.1002/ijc.10367. Int J Cancer. 2002. PMID: 11992555

7

Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families.

Cavaciuti E, Laugé A, Janin N, Ossian K, Hall J, Stoppa-Lyonnet D, Andrieu N. Cavaciuti E, et al. Genes Chromosomes Cancer. 2005 Jan;42(1):1-9. doi: 10.1002/gcc.20101. Genes Chromosomes Cancer. 2005. PMID: 15390180

8

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; Institut Curie Breast Cancer Study Group. Kirova YM, et al. Eur J Cancer. 2005 Oct;41(15):2304-11. doi: 10.1016/j.ejca.2005.02.037. Epub 2005 Sep 1. Eur J Cancer. 2005. PMID: 16140006

9

Ataxia-telangiectasia genes and breast cancer risk in a French family study.

Andrieu N, Cavaciuti E, Laugé A, Ossian K, Janin N, Hall J, Stoppa-Lyonnet D. Andrieu N, et al. J Dairy Res. 2005;72 Spec No:73-80. doi: 10.1017/s0022029905001147. J Dairy Res. 2005. PMID: 16180724

10

Increased risk of breast cancer among female relatives of patients with ataxia-telangiectasia: a causal relationship?

d'Almeida AK, Cavaciuti E, Dondon MG, Laugé A, Janin N, Stoppa-Lyonnet D, Andrieu N. d'Almeida AK, et al. Br J Cancer. 2005 Sep 19;93(6):730-2; author reply 732. doi: 10.1038/sj.bjc.6602786. Br J Cancer. 2005. PMID: 16222317 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

491 results

Search Page

Filters